kallyope glp-1 program Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers GLP-1s are great, but researchers

PMID: 32928579

Notably, dual GIP and GLP-1 receptor agonists produced more potently inhibited AgRP neurons and suppressed food intake than either agonist alone ( In line with these finding, Lai S et al

Commercial plans through Cincinnati employers vary widely

Everyones likelihood of risks and benefits is highly individualized, but these medications can touch on very personal issues, like weight status, weight stigma, body image, chronic illness management, and future disease risk, which must be carefully considered and handled with compassion plus a focus on currently available scientific evidence

This monitoring allows for adjustments in insulin dosages and troubleshooting of any issues to maintain optimal glucose control

6:48 PM Apr 1, 202610.8KViews3031101159059101Read 3 replies